Autophagy deactivation is associated with severe prostatic inflammation in patients with lower urinary tract symptoms and benign prostatic hyperplasia

被引:13
|
作者
De Nunzio, Cosimo [1 ]
Giglio, Simona [2 ]
Stoppacciaro, Antonella [2 ]
Gacci, Mauro [4 ]
Cirombella, Roberto [2 ]
Luciani, Emidio [2 ]
Tubaro, Andrea [1 ]
Vecchione, Andrea [2 ,3 ]
机构
[1] Sapienza Univ, Osped St Andrea, Dept Clin & Mol Med, Urol Units, Rome, Italy
[2] Sapienza Univ, Osped St Andrea, Dept Clin & Mol Med, Surg Pathol Units, Rome, Italy
[3] Ohio State Univ, CCC, Dept Canc Biol & Genet, Columbus, OH 43210 USA
[4] Careggi Hosp, Dept Urol, Florence, Italy
关键词
autophagy; BPH; LUTS; inflammation; prostate; METABOLIC SYNDROME; REGULATES INFLAMMATION; PATHOGENESIS; OBESITY;
D O I
10.18632/oncotarget.15144
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Autophagy is a conserved evolutionary process that allows cells to maintain macromolecular synthesis and energy homeostasis during starvation and stressful conditions. We prospectively evaluated the relationship between autophagy and prostatic inflammation in a series of transurethral prostatic resection samples. Inflammatory infiltrates were defined according to the standardized classification of chronic prostatitis of the National Institute of Health. The inflammatory score (IS score) was calculated. High IS score was defined as >= 7. Each sample was stained for anti-LC3B and for anti-P62/SQSTM1 and scored. High p62 or LC3B percentage was defined as > 25%, whereas low was defined as < 25% of cells with dots. We analyzed 94 specimens. Overall, 18/94 (19%) showed no sign of prostatic inflammation, whereas 76/94 (81%) presented inflammatory infiltrates. Inflammation was mild in 61/76 (80%), moderate/severe in 15/76 (20%). Patients with high p62 percentage were 62/94 (66%) while 32 (34%) showed low p62 percentage. Patients with high LC3B percentage were 37/94 (39%) while 57(61%) showed low LC3B percentage. Overall 42/94 (44%) patients presented a high p62 percentage and concomitant a low LC3B percentage. IS score was significantly higher in patients with a with high p62 percentage (median IS 7 (6/8) vs 5 (3/7); p=0.04) and in patients with a low LC3B percentage (median IS 7 (6/8) vs 5 (3/7); p=0.004) when compared to patients with a low p62 percentage or a high LC3B percentage respectively. On multivariate analysis, p62 (OR: 10.1, 95% CI: 2.6-38.6; p=0,001) and LC3B expression (OR: 0.319; 95% CI: 0.112-0.907; p=0.032) were independent predictors of a high IS. Here we present the first evidence of autophagy deregulation in prostatic inflammation. These results raise many questions about the mechanisms mediating the autophagy dysfunction and the links to prostatic inflammation that need to be addressed.
引用
收藏
页码:50904 / 50910
页数:7
相关论文
共 50 条
  • [11] Lower urinary tract symptoms, benign prostatic hyperplasia, and obesity
    McVary K.T.
    Mongiu A.K.
    Current Urology Reports, 2009, 10 (4) : 247 - 253
  • [12] Benign Prostatic Hyperplasia and the Medication Management of Associated Lower Urinary Tract Symptoms
    Knezevich, Emily L.
    Knezevich, Jon T.
    Spangler, Mikayla L.
    US PHARMACIST, 2011, 36 (06)
  • [13] Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia, and Urinary Retention
    Alawamlh, Omar Al Hussein
    Goueli, Ramy
    Lee, Richard K.
    MEDICAL CLINICS OF NORTH AMERICA, 2018, 102 (02) : 301 - +
  • [14] Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms
    McNicholas, Tom
    Kirby, Roger
    AMERICAN FAMILY PHYSICIAN, 2012, 86 (04) : 359 - 360
  • [15] Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia
    Gallegos, Patrick J.
    Frazee, Lawrence A.
    PHARMACOTHERAPY, 2008, 28 (03): : 356 - 365
  • [16] Mast cells play a critical role in driving prostatic inflammation in Lower Urinary Tract Symptoms associated with Benign Prostatic Hyperplasia
    Pattabiraman, Goutham
    Bell-Cohn, Ashlee Justine
    Murphy, Stephen Fintan
    Schaeffer, Anthony J.
    Thumbikat, Praveen
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [17] Correction to: Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia
    Cosimo De Nunzio
    Andrea Salonia
    Mauro Gacci
    Vincenzo Ficarra
    World Journal of Urology, 2020, 38 : 2781 - 2781
  • [18] Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What Is the Role and Significance of Inflammation?
    Lloyd, Granville L.
    Marks, Jeffrey M.
    Ricke, William A.
    CURRENT UROLOGY REPORTS, 2019, 20 (09)
  • [19] Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What Is the Role and Significance of Inflammation?
    Granville L. Lloyd
    Jeffrey M. Marks
    William A. Ricke
    Current Urology Reports, 2019, 20
  • [20] Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia
    Michel, MC
    Mehlburger, L
    Schumacher, H
    Bressel, HU
    Goepel, M
    JOURNAL OF UROLOGY, 2000, 163 (06): : 1725 - 1729